Next Article in Journal
Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors
Next Article in Special Issue
Model Re-Estimation: An Alternative for Poor Predictive Performance during External Evaluations? Example of Gentamicin in Critically Ill Patients
Previous Article in Journal
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
Previous Article in Special Issue
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(6), 1304; https://doi.org/10.3390/pharmaceutics14061304
Action Date Notes Link
article xml file uploaded 20 June 2022 09:37 CEST Original file -
article xml uploaded. 20 June 2022 09:37 CEST Update https://www.mdpi.com/1999-4923/14/6/1304/xml
article pdf uploaded. 20 June 2022 09:37 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1304/pdf
article html file updated 20 June 2022 09:38 CEST Original file -
article html file updated 12 August 2022 21:19 CEST Update https://www.mdpi.com/1999-4923/14/6/1304/html
Back to TopTop